Abstract Background Elevated levels of depressive symptoms are generally found among cancer patients, but results from existing studies vary considerably with respect to prevalence and proposed risk factors. Purpose To study the prevalence of depressive symptoms and major depression 3-4 months following surgery for breast cancer, and to identify clinical risk factors while adjusting for pre-cancer sociodemographic factors, comorbidity, and psychiatric history. Patients and methods The study cohort consists of 4917 Danish women, aged 18-70 years, receiving standardized treatment for early stage invasive breast cancer during the 2 1/2 year study period. Of these, 3343 women (68%) participated in a questionnaire study 12-16 weeks following surgery. Depressive symptoms (Beck's Depression Inventory II) and healthrelated behaviors were assessed by questionnaire. The Danish Breast Cancer Cooperative Group (DBCG) and the surgical departments provided disease-, treatment-, and comorbidity data for the study cohort. Information concerning sociodemographics and psychiatric history were obtained from national longitudinal registries. Results The results indicated an increased prevalence of depressive symptoms and major depression (13.7%) compared to population-based samples. The pre-cancer variables: Social status, net-wealth, ethnicity, comorbidity, psychiatric history, and age were all independent risk factors for depressive symptoms. Of the clinical variables, only nodal status carried additional prognostic information. Physical functioning, smoking, alcohol use, and BMI were also independently associated with depressive symptoms. Conclusion Risk factors for depressive symptoms were primarily restricted to pre-cancer conditions rather than disease-specific conditions. Special attention should be given to socio-economically deprived women with a history of somatic-and psychiatric disease and poor health behaviors.
Introduction
While depressive disorders are generally believed to be more prevalent in breast cancer patients than in the general population, the literature indicates considerable variability [1] , with rates from 0-2% [2, 3] up to 55% [4] . Previous studies have generally used relatively small samples of convenience with varying demographic characteristics. The variability of the results could also stem from methodological differences between studies, including the criteria used to define depression, the timing of assessment, disease stage, and treatment status of the women.
Older age is generally associated with reduced emotional expressivity [5, 6] , and older women with breast cancer experience report fewer depressive symptoms [7] . Other age-related differences in health status, treatment, and social support may also play a role together with sociodemographic factors such as marital status [8, 9] , number of children [10] , and socio-economic status [11] .
Several studies have used structured psychiatric interviews to assess depression according to diagnostic criteria, primarily as defined in DSM-III [12] or DSM-IV [13] , while others have measured depressive symptoms using rating scales such as the Center for Epidemiological Studies Depression Scale (CES-D) [14] , the Hospital Anxiety and Depression Scale (HADS) [15] , or the Beck Depression Inventory (BDI), [16, 17] . These instruments generally compare well [18, 19] and seem suitable for assessing depression in cancer patients [19, 20] . The HADS, however, may be less suitable than other measures [21] [22] [23] [24] .
There is considerable variation in the timing of assessment both between-and within studies, with recently diagnosed patients being assessed over time-spans of several months [25, 26] , and disease-free breast cancer survivors being assessed from a few months to 18 years after diagnosis [2, [27] [28] [29] . The available data indicate that cancer-related distress generally diminishes with time after diagnosis [10, [30] [31] [32] , increasing again after a possible recurrence [33, 34] .
There are also considerable within-and between study differences with respect to the disease and treatment characteristics. Some studies only include patients with early stages of breast cancer [35, 36] , while others have investigated more advanced breast cancer [11, 23, 37] . Stage of disease and tumor grade have been reported inconsistently related to psychological problems in cancer and is generally uncorrelated with depression in breastcancer [38] [39] [40] [41] . While breast conserving surgery has been found associated with better body image [42] and lower prevalence of depression [27] , there is no clear indication that depression is associated with type of surgery [32, 43, 44] . Radiotherapy [45] and tamoxifen [46, 47] has previously been linked to depression in breast-cancer, but more recent studies have not confirmed these findings [41, [48] [49] [50] . There are conflicting results concerning the possible role of chemotherapy [48, 50] and estrogen receptor status [39, 50, 51] .
More consistent associations have been found with physical function [41, 52, 53] and overweight [54] , whereas the role of poor health behaviors are less frequently investigated [41] .
In an ageing population the prevalence of coexisting medical diseases in addition to cancer becomes increasingly important [55, 56] . Depression is common not only among cancer patients but also in other medical illnesses such as diabetes and cardiovascular diseases [57, 58] , these being the most common coexisting illnesses in cancer patients [59] . Comorbidity may thus confound possible associations between depression and factors such as treatment or age.
Finally, the generalizability of results may suffer from unknown differences between participants and non-participants, introducing potential confounding by factors such as socio-economic status, comorbidity and psychiatric history. However, in the available studies, these factors are rarely explored.
Aim of the study
While the literature suggests that women treated for breast cancer may be at increased risk of depression, there is considerable variability in the results and proposed risk factors, which may stem from methodological betweenstudy differences, and studies using large population-based samples are needed. In the present study, we present data, collected at baseline, from a large prospective nation-wide cohort study of Danish women recently treated for early stage breast cancer, with the aim of assessing the prevalence of depressive symptoms and investigating the role of potential risk factors, including disease-and treatmentrelated factors, demographic-and socio-economic factors, psychiatric history, and medical comorbidity.
Methods

Study design
The present study is designed as a nationwide prospective cohort study and consists of 4917 women surgically treated for early stage invasive breast cancer in Denmark between October 2001 and March 2004. The study is conducted in collaboration with The Danish Breast Cancer Cooperative Group (DBCG) and the 24 largest surgical departments responsible for treating breast cancer in Denmark during the inclusion period. Data concerning eligibility, comorbidity, histopathology, and treatment-related variables were obtained from the DBCG registry as well as from the surgical departments. Demographics, psychiatric history and socio-economic variables were obtained from the unique Danish longitudinal registries. At baseline, 12-16 weeks post-surgery, 3343 (68.0%) women from the cohort also provided extensive information regarding health behaviors, health status, and psychosocial variables through a mail-out questionnaire.
Eligibility
Eligible patients were aged 18-70 years, Danish residents with histologically confirmed stage I or II breast cancer T1-3, N0-3, and M0 according to the TNM classification [60] and no history of other cancers except non-melanoma skin cancer or carcinoma in situ of the cervix uteri. The ability to read Danish, being physically/mentally capable of completing a questionnaire, and allocation to one of the five existing standard DBCG treatment protocols was also required. The protocols were: (A) No adjuvant therapy; (B) Seven courses of chemotherapy (CEF) followed by endocrine treatment for 5 years; (C) Endocrine treatment for 5 years, and (D or E) Seven courses of chemotherapy with CEF or CMF. Women treated with lumpectomy, or who had tumor positive lymph nodes in the axillae and/or nonradical surgery and/or tumors with a diameter [50mm were also allocated to radiotherapy.
Procedure
Eligible women were informed orally and in writing about the study at the surgical departments. The Charlson Comorbidity Index [61] was completed by a physician together with a form indicating the date of surgery, each patient's unique personal identification number (CPRnumber), and information regarding eligibility for each woman. Data were sent to the Study Secretariat at the Psychooncology Research Unit at Aarhus University Hospital on a monthly basis. Addresses of eligible women were obtained from the DBCG registry on a monthly basis during the study period, or directly from The Danish Civil Registration System (DCRS), using the CPR-numbers on the Charlson forms. Eligible women were mailed an informed consent form, additional information, a questionnaire package, and a prepaid return envelope, and invited to participate in the study 12-16 weeks after surgery. A hotline telephone and e-mail service was offered to answer questions regarding the study and the questionnaire. If the questionnaires and the written consent form were not returned within 3 weeks, a single reminder was sent. The questionnaires were designed, processed and verified using optical scanning and software (Teleform 7.1; Cardiff). Approval of the study was obtained from The Regional Science-Ethical Committees and The Danish Data Protection Agency. Subjects DBCG and/or the collaborating surgical departments initially identified a total of 5441 women as being potentially eligible for the study. Of these, 237 women (4.4%) received treatment at one of the 11 minor surgical departments not participating in the study and were hence excluded. Information from the surgical departments showed that 68 women had a previous cancer disease unknown to the DBCG at the time and that an additional 24 women did not receive standard treatment (typically neoadjuvant chemotherapy). Furthermore, 99 women were considered unable to read Danish sufficiently well by the surgical departments or as being physically/mentally incapable to fill in a questionnaire. Three women had distant metastases diagnosed within 12 weeks post-surgery, and two women who had left the country within the same time period were also excluded. One woman was reported by her relatives to be hospitalized due to psychiatric illness, and one woman was shown to have had surgery prior to the study period.
In all, 5,006 women were thus eligible for the study. Subsequently seven women who had chosen to block scientific access to their addresses through their CPR-number, and two women who withdrew their consent were deleted from the database. Finally, 80 women were excluded in order to minimize zero-time bias, because their data and addresses were not available within 28 weeks post-surgery.
A total of 4,917 women thus constituted the study cohort. Of these, 3343 women (68.0%) returned a valid questionnaire. The majority of the questionnaires (91%) were mailed out 12-16 weeks after primary surgery. The remaining questionnaires were mailed out during the following three months.
Measures
Depressive symptoms
The 21-item Beck Depression Inventory -Second Edition (BDI-II) is a widely used questionnaire developed for the assessment of symptoms corresponding to criteria for diagnosing depressive disorder listed in The American Psychiatric Associations Diagnostic and Statistical Manual of Mental Disorders -Fourth Edition (DSM-IV). According to the manual, a cut score of 17 has yielded a 93% truepositive rate and 18% false-positive rate for the presence of major depression [17] . Its two factor-analytically derived subscales measuring somatic-and cognitive/affective depressive symptoms respectively, makes it particularly useful in medical ill populations in terms of identifying the potentially disease-, and treatment-related symptoms of depression. Internal consistency (Chronbach's Alpha) was satisfactory (Total: 0.90; Somatic symptoms: 0.75; Cognitive/Affective symptoms: 0.89).
Physical function (PF)
The SF-36 PF 10 item subscale was used to measure physical functioning. The SF-36 is a widely used measure of health related quality of life and PF measures limitations chiefly in basic daily physical activities such as lifting or carrying groceries, climbing stairs etc. There are three response types: ''Yes limited a lot'' (=1), ''Yes limited a little'' (=2) and, ''No not limited at all'' (=3). Individual scores were calculated as outlined in the manual: 100 9 ((Sum scorelowest possible score (i.e. 10)) / (Highest possible raw score (i.e. 30) -lowest possible score (i.e. 10))). This transformation yields a score range from 0 (lowest PF) to 100 (best PF) [62, 63] . Internal consistency was satisfactory (Chronbach's alpha = 0.86).
Health behaviors and BMI
Data on health behaviors and BMI were obtained by questionnaire. BMI was calculated as: current weight (Kg)/ Height (m 2 ) and categorized according to WHO guidelines [64] : Underweight (BMI B 18.5); Normal weight ([18.5 and \25); Overweight (C25 and \30); Obese and severely obese (C30) were collapsed due to few observations (\3%) among severely obese. Alcohol intake was measured as total self-reported consumption during the past seven days and is presented in units per day (beers, glasses of wine or drinks). Ex-drinkers were defined as previous users who had stopped drinking. Never smokers and ex-smokers were categorized separately.
Comorbidity
The Charlson Comorbidity Index (CCI) [61] is a widely used measure of nineteen comorbid conditions that can alter the risk of mortality in longitudinal studies. CCI has been validated among breast cancer patients and the weighted index score takes into account the number and the seriousness of comorbid disease [55, 65] . Cancer specific conditions are not included in the present study since patients with previous malign cancers or metastatic tumors were not eligible. Missing data identified through a linkage with the DBCG registry were requested from the departments every third month.
Clinical variables and treatment
Data on histopathology and treatment-related variables from all eligible patients were obtained through a linkage with the DBCG registry. DBCG was established in 1976 with the aim of ensuring optimal diagnostics and treatment of operable primary breast cancer on a nation-wide basis. DBCG has worked out uniform national guidelines and the participants include all departments of surgery, pathology, radiotherapy, and oncology involved in the treatment of breast cancer in Denmark. The departments provide data to the DBCG on a regularly basis. A previous study [66] has shown that only 3% of all eligible patients fulfilling the criteria's of enrollment in a DBCG protocol between 1978 and 1994 where missing when validating the DBCG registry against The Danish Cancer Registry. Less than one percent was registered by the DBCG but missing in the Danish Cancer Registry. It was also shown that the completeness of the DBCG registry was improving through the study period. The data provided by the DBCG in the present study can therefore be considered as nearly complete.
Sociodemographics
Since 1968, all Danish residents have been assigned a 10-digit personal identification number (CPR-number) by the DCRS, which is used across all public registration systems, making linkages with a large number of registry-based data sources possible. Data were collected through a linkage with six of the nationwide Danish longitudinal registers available for researchers. All registries are administered by the central government agency of statistics in Denmark (Statistics Denmark) [67] except the Danish Psychiatric Central Research Registry, which is administered by the Department of Psychiatric Demography at Aarhus University Hospital. The linkage of all registries was serviced by Statistics Denmark. Age at the time of surgery was calculated on the basis of the CPR-number and time of surgery. All sociodemographic variables refer to pre-cancer conditions either in the year prior to the date of surgery minus one month or, when appropriate, at the date of surgery minus one month. The following registries were used:
The Registry of Income Statistics: (Personal income, netwealth). The registry is based on the information that banks, employers and others who pay out wages and salaries, remunerations, pensions etc. are required to report to the tax authority. Income was adjusted for the yearly wageincreases for women in Denmark by a weighted average of the three indices of the average earnings in the private-, and public sector (local-and central government) published by Statistics Denmark. The weights were calculated on the basis of the occupational distribution in the 2002 indices for women, also published by Statistics Denmark. Due to the significant fluctuations on the financial markets in the study period and a low Danish core inflation rate in the study period net-wealth was left unadjusted. A mean household net-wealth variable (excluding principal shareholder positions and value of privately held enterprises) was calculated by using the mean total net-wealth for cohabiting couples. The amounts in Danish kroner (Kr.) were subsequently converted into US dollars ($) on the basis of the exchange rates published by Danmarks Nationalbank (Basis: 12/31 2003).
The Registry-based labor-force statistics (RAS): (Social status). RAS Statistics provides a description of the Danish populations attachment to the labor market and follows the guidelines set by the International Labour Organisation (ILO). RAS Employee skill level acquired through education or learning in praxis is defined on the basis of the Danish version of the European Unions official nomenclature for occupations, ISCO-88 (International Standard Classification of Occupations).
The Registry for Education of the Population (BUE): (Level of Education). Level of education was coded according to UNESCO's International Standard Classification of Education (ISCED-97) nomenclature [68] . Because a significant proportion of the women had 7 years of education, the Lower secondary general category was divided into two categories: 7 years (mandatory for the elderly in the cohort) and 8-10 years. At the tertiary level, data are categorized as pre-, and post master degree. The approximate corresponding years of schooling are indicated in the tables.
Integrated Database for Labor Market Research (IDA): (Marital status, ethnicity and urbanicity). The group of immigrants/descendants is defined by Statistics Denmark as persons for whom neither of their parents are Danish citizens born in Denmark. Women were defined as cohabiting when registered at the same address as one nonrelated male adult and no other adults. Married, but not cohabiting women were categorized as separated. The urbanicity variable was categorized on the basis of municipality sizes in the year 2002.
The Fertility Database: (Number of children). The database includes information on date of birth and death of children of Danish residents. We calculated the number of children alive at the time of surgery.
The Danish Psychiatric Central Research Registry (DPCR). DPCR is a nationwide administrative registry to which psychiatric inpatients treated in Denmark has been reported since 1969. Since 1995, outpatients have been registered as well [69] . In the present study, psychiatric history was coded as positive in case of psychiatric hospitalization for any reason until one month pre-surgery. From 1995, outpatient history was also coded as positive.
Missing values
Participants were specifically instructed to check for missing answers before returning the questionnaire. The following procedure was applied: Subscale totals with more than 50% missing values were coded as missing and no total score was calculated. Missing values on subscales with an alpha [ 0.7 were substituted with the mean of the remaining filled items on the subscale. This procedure is identical to the procedure described in the manual of SF-36 and is regarded as adequate and preferable to procedures such as list-wise deleting or scale mean-substitution of scale-scores when one or more values are missing [62, 70] .
Statistical analysis
Response rates were computed in categories of each variable and the unadjusted association with non-response was assessed by Chi 2 -test. Subsequently the associations were evaluated simultaneously by a logistic regression analysis with response to the questionnaire (yes or no) as the dependent variable. The results of the logistic regression were presented as adjusted odds ratios (OR).
For each variable an unadjusted comparison of BDI scores across categories was carried out by a KruskalWallis test. Next, a negative binomial regression model was used to evaluate the association of each variable with total BDI score adjusted for the influence of other variables. Results of these analyses were presented as a Ratios of Means (RM), which gives the expected BDI score in a category relative to the expected BDI score in the reference category.
The independent variables considered in the regression models referred to three phases of the woman's cancer history: Pre-cancer, peri-surgery and post-surgery, and data were analyzed accordingly. Demographics and health status data were analyzed in the first step, since these data refer to pre-cancer conditions and therefore are unbiased by the cancer experience. Information and experiences related to the disease and its treatment had been known to the women for more than 2 months, when the questionnaire was completed. Clinical variables were therefore analyzed in the second step. Post-cancer health behaviors and other health-related variables might be moderated by the cancer diagnosis and treatment, and were therefore analyzed in the third step. At each step, we report the unadjusted stratified mean values and the prevalence of major depression as percentages. At step 2 and 3, we also report RM adjusted for all variables included at the previous steps in the analysis as well as age-adjusted RM. Finally, we considered a total risk-model for the prevalence of depressive symptoms 3-4 month post-surgery using backward negative binomial regression analysis. Supplementary analyses of the somatic and the cognitive/affective subscales of BDI were also performed. In order to validate and elaborate our findings, we also applied logistic regression analysis to calculate the odds ratios for major depression for the identified risk factors. Age was treated as a continuous variable in all multivariate analyses.
The nbreg procedure in STATA 9.2 for UNIX was used for the negative binomial regression analyses; all other analyses were conducted with SPSS 14.0.1 for Windows 2000.
Results
Non-responders
Data on psychiatric history, co-morbidity, socio-demographics, and histopathology and treatment for each variable were obtained for at least 98.5% of all eligible women, allowing a nearly complete comparison of questionnaire responders with non-responders (Table 1) . When adjusting for age, neither histopathology nor treatmentrelated variables were significantly related to response rate (all P-values [.21). Also, there were no differences in participation related to DBCG's five standard treatment protocols (P = .38, data not shown). In contrast, psychiatric history, comorbidity and all the sociodemographic variables, except having children (P = .06), were found to be significantly associated to response rate when controlling for age (Table 1) . Responders were generally younger, better educated, had higher incomes, higher mean netwealth, higher social status (employed in jobs requiring medium to high skill levels, excluding self-employed or assisting spouses), and were more likely to be married or cohabiting. Lower participation was found for women having a psychiatric history, serious comorbid disease, for immigrants/descendants, and residents of the center of Copenhagen.
Depression
Total BDI-II scores could be calculated for all but 22 women (n = 3321) and only 46 respondents had more than one missing item on the BDI. Median age was 55.7 years (range: 26-70 years) and mean BDI Total score was 8.85 (SD = 7.44). Mean scores on the somatic-, and cognitive/affective subscales were 3.59 (SD = 2.38) and 4.48 (SD = 5.25) respectively. In all, 13.7% had a BDI score above or equal to 17 and could thus be classified as suffering from major depression. BDI scores of responders who returned the reminder questionnaire (n = 444) did not differ significantly from scores of the remaining responders (P = .26). Time from surgery to the first questionnaire was mailed out was not associated to the BDI score (Rho = -.008; P = .64). For major depression, the overall proportion of users of prescribed anti-depressive medications or anxiolytica for more than 3 days the previous month was 35%.
When adding women who had consulted a psychiatrist or psychologist more than once since diagnosis, the percentage was 51% (data not shown).
Sociodemographic-and health-related risk factors for depressive symptoms A significant negative correlation was found between age and BDI total scores (Rho = -.17; P \ .001), with fewer depressive symptoms found among the 50-69 year old women compared to the 18-35 year old women. Nearly a third of the patients with a psychiatric history (33%) or with a score above one point on the Charlson Comorbidity Index (30%) were classified as suffering from major depression. In the age-adjusted analyses, risk factors for depressive symptoms were: Younger age, low income (B20.000$), negative net-wealth, low social status (being outside the workforce, i.e. old age pensioners, unemployed etc. and recipients of early retirement pension etc.), less education, being divorced/separated, and having a history of somatic-or psychiatric disease (Table 2 ). When entering all the sociodemographic variables into a regression analysis with additional adjustment for psychiatric history and comorbidity, the independent pre-cancer risk factors for depressive symptoms were: Younger age, psychiatric history, comorbidity, being a recipient of early retirement pension, rehabilitation-or sickness benefits, and having a negative mean household net-wealth. In addition, an increased prevalence of depressive symptoms among immigrants and descendants was observed (P = .05) ( Table 2) .
Clinical risk factors for depressive symptoms
In the unadjusted analyses, higher levels of depressive symptoms were predicted by axillary lymph node involvement, pre-menopausal status, and treatment with chemotherapy (Table 3) . After adjustment for age, only axillary lymph node involvement ([3) was a risk factor (RM = 1.11, 95% CI = 1.03-1.20). The age-adjusted analyses revealed no further influence of disease-and treatment-related factors (all P [ .11), including the five standard DBCG treatment protocols (P = .10, data not shown). Additional adjustment for sociodemographics-, psychiatric history and comorbidity resulted only in minor and insignificant changes ( Table 3) .
Analyses of the subscale scores on the BDI while adjusting for age, pre-cancer health status, and sociodemographic variables revealed that the observed effects for both lymph node involvement was driven by an association with the somatic subscale of the BDI (P \ .001), while there were no associations with scores on the cognitive/ affective subscale (P = .38). When entered into a logistic regression with major depression vs. no major depression as the dependent variable while adjusting for age and sociodemographic factors, nodal status only exhibited a trend towards being a risk factor for major depression (P = .07, data not shown). Results of similar analyses of all other clinical variables, including treatment, did not reach statistical significance (all P [ .30, data not shown).
Health behavior, health status and depressive symptoms
Smoking status: In the age-adjusted analysis more depressive symptoms were found among women smoking more than 9 cigarettes per day compared to never-smokers. After full adjustment, only the consumption of 20 or more cigarettes per day was associated with depressive symptoms (Table 4 ). The results of the fully adjusted analysis applied to both the somatic (P \ .001) and the cognitive/affective component (P \ .001) of the BDI (data not shown).
Alcohol consumption: After adjustment for sociodemographic-and clinical variables, only the consumption of three or more units per day showed to be significantly related to depressive symptoms compared to never drinkers (Table 4 ). This applied to both the somatic (P = .01) and the cognitive/affective subscale (P = .001) of the BDI (data not shown).
Body mass: In the age-adjusted analysis, overweight, obese or severely obese women reported significantly more depressive symptoms compared to women with normal weight. This association remained relatively unaffected in the fully adjusted analysis (Table 4 ). This effect was most pronounced for the somatic subscale of the BDI (P \.001) (data not shown).
Physical functioning: A strong association was observed between physical function and the prevalence of depressive symptoms ( Table 4 ). The mean BDI-score of women with a SF-36 score below or equal to 70 was nearly 2.5 fold higher than for women with a score of 100. The corresponding prevalence of major depression was more than five fold higher (30.6% vs. 5.8%). The strength of the association in the age-adjusted analysis of depressive symptoms was only minimally affected in the fully adjusted analysis. The association applied to both the somatic (RM = 2.39, 95% CI = 2.21 to 2.59, P \ .001) and the cognitive/affective subscale (RM = 2.72, 95% CI = 2.36 to 3.14, P \ .001) of the BDI (data not shown).
In the fully adjusted analysis, both comorbidity and axillary lymph node involvement ceased to be statistically significant predictors when physical function was added as a covariate, but remained independent predictors, when smoking status, BMI, and alcohol consumption were added separately as covariates.
Independent predictors of depressive symptoms and major depression
The results of a backward regression analysis including all the presented independent variables (P \.05) are presented in Table 5 . Independent predictors of depressive symptoms 12-16 month post-surgery were: Younger age, being divorced or separated, being immigrant or descendant, having a positive psychiatric history, belonging to an uppermiddle household (i.e. having a mean net-wealth of 55-120.000$), smoking more than 20 cigarettes per day, and reporting reduced physical functioning (\100). Moderate alcohol consumption (C1 and \2 units per day) was an independent predictor of fewer depressive symptoms. When entering all the identified independent predictors of depressive symptoms into a logistic regression with major depression vs. non-depressed as the dependent variable, the results generally supported these findings. The fully adjusted odds ratio of suffering from major depression when having a physical function score below or equal to 70 compared to a score of 100 was 7.38 (95% CI = 4.77-11.41).
Discussion
The present study is, to the best of our knowledge, the first nationwide prospective study of risk factors and the prevalence of depressive symptoms and major depression following breast cancer. Further strengths include: A large sample size; Admission to data on nearly all eligible cases during the study period; Nationwide standardized treatment; A prospective design using unbiased measures of pre-cancer demographics; Application of a consecutive inclusion procedure at a well-defined point in time 12-16 weeks following surgery in order to reduce potential zero-point bias; Acceptable questionnaire response rate and highly detailed data on histopathological-, treatment-, sociodemographic-and health related variables for both participants and non-participants. A mean score of 8.85 on the BDI-II and a point prevalence of major depression (MD) of 13.7% 12-16 weeks after surgery were observed. In a sample of 187 randomly selected Danish women a mean score of 7.1 on the BDI-II [71] and a prevalence of MD of 10.7% was found (unpublished data: Zachariae, R.). In another Danish study also using the BDI-II [72] , a MD prevalence of 12.1% in a randomly selected sample of 109 younger women aged 20-35 yrs., and 3.0% among 133 elderly women aged 70-85 years. was found (unpublished data: Zachariae, R.). In the present study, the indicated prevalence of MD among 18-35 year olds was 17.9%, while the prevalence was 11.2% among the eldest (60-69 years). In a study of 616 randomly selected Danish women aged 20-79 years. the point prevalence of MD was 3.6% while using the Major Depression Inventory, corresponding to a prevalence of 8.8% of minor and major depression on the Hamilton Depression Scale [73] . In the US, the 12-month point prevalence for MD was 6.6% according to the National Comorbidity Survey Replication study [74] while prevalence in Europe generally is found to be somewhat lower (3-5%) [73] .
Our results thus suggest, that the prevalence of major depression and depressive symptoms is increased following surgery for invasive breast cancer.
Of the cancer-and treatment related variables, only nodal status ([3) was a modest risk factor for increased depressive symptoms and only marginally so for major depression. The generalizeability of this finding is supported by the finding that participation in the questionnaire study, when adjusting for age, was neither biased by histopathological nor treatment related variables. This result can therefore be seen as being in general accordance with the negative findings in a large USsample, although histopathological-and treatment related variables were specified in less detail and nodal status was not analysed separately in that study [41] . The results raise the question why the level of depressive symptoms following a diagnosis of breast cancer is increased, while generally unpredicted by any of a detailed set of cancerand treatment related variables? A straightforward answer could be that what matters most to women having early stage breast cancer, is the cancer per se-i.e. the personal-, social-and economic implications of having a potentially life-threatening disease. Our finding that nodal status was the only cancer-and treatment related risk factor for depression may reflect that the prognostic significance of nodal spread may be the only clinical variable commonly perceived by the women as having a negative prognostic influence.
In contrast to treatment-and disease characteristics, sociodemographics, comorbidity, and psychiatric history, were consistently found to be risk factors for both depressive symptoms and major depression. Poor health behaviours (i.e. extensive smoking or drinking), being overweight and low levels of physical functioning were independently associated with higher levels of depressive symptoms in the fully adjusted analysis. Due to the cross-sectional nature of this part of the data set, it may be that physical functioning and extensive drinking and smoking 12-16 weeks following surgery in part could be a consequence of depressive symptomatology following breast cancer, rather than the opposite causal direction. However, with respect to physical functioning, the mean score for women aged 45-54 on the SF-36 PF was 85.5 (SD = 15.3) and thus similar to Danish norms (86.2; SD = 20.1) [62] . For women aged 55-64 the mean score was in fact somehow higher 83.5 (SD = 17.3) a MD = Prevalence of major depression (BDI-II scores C 17); CI = Confidence interval; RM = Ratios of Means. RM in bold differs significantly (95% CI) from the reference group (RM = 1.00) b Fully adjusted for socio-demographic variables (age, marital status, children, education, urbanicity, social status, personal income, household net-wealth and ethnicity), psychiatric history and comorbidity compared to norms 78.0 (SD = 24.8). Physical functioning as measured by the SF-36 may therefore not be a consequence of early breast cancer in any substantial degree but rather a true risk factor for depression as well as major depression. Low physical functioning was strongly associated to both the somatic-and the cognitive/affective BDI subscales, and the question remains whether some women are attributing their low level of physical functioning to a possible recurrence. Ethnicity also emerged as an independent significant predictor in the final model (Table 5 ).
There may exist cultural barriers in the Danish health system adding to the stress of the disease for these women. If so, it is likely that the problems are even more pronounced in ethnic minorities since only those being able to read Danish were included in the study, and those who were not could be even worse off.
In the US 51.6% of all MD cases have been found to receive treatment [74] whereas only 13.2% MD cases were in treatment by a medical doctor for a nervous/mental disease in a Danish population based sample [73] . In the present study we found that 35% were in medical treatment for nervous/mental disease. Compared to Danish norms the treatment rate is therefore higher, but a substantial number of Danish women treated for invasive breast cancer remain untreated for a possible major depression.
When comparing responders with non-responders in the total study cohort, lower participation was generally seen in groups that were at increased risk of depression with the exception of younger women. However, we found no differences in depressive symptoms between women who returned the reminder when compared to those who returned the first questionnaire. Nonetheless, it is likely that a MD = Prevalence of major depression (BDI-II scores C 17); CI = Confidence interval; RM = Ratios of Means. OR and RM in bold differs significantly (95% CI) from the reference group (OR = 1.00 or RM = 1.00) b First column: Independent predictors of depressive symptoms (P \ .05), identified by backward regression analysis including all clinical factors (tumor size, nodal status, tumor grade, ER/PR receptor status, menopausal status, surgery, chemotherapy, radiotherapy and hormone therapy), all socio-demographic variables (age, marital status, children, education, urbanicity, social status, personal Income, household netwealth and ethnicity), psychiatric history, comorbidity and self-reported health behaviors (smoking, use of alcohol), body mass index and physical function. Second column: Unadjusted RM and CI. Third column: Age-adjusted OR and CI for major depression. Fourth column: OR and CI for major depression fully adjusted for all independent predictors identified in the backward regression analysis (N = 3190). c Unadjusted the true level of depression in the study cohort may be somehow underestimated. The finding that women with an indication of major depression were more than 2.5 times likely to be in treatment for nervous/mental disease compared to a population based Danish sample, thereby reducing the ''natural'' level of depressive symptoms following breast-cancer, may further add to such a bias.
Conclusion
The present study confirms that the prevalence of major depression and depressive symptoms is increased among women treated for early stage breast-cancer. Concerns have been raised with respect to potentially adverse consequences of treatment for breast-cancer, e.g. chemotherapy, radiotherapy, mastectomy, and tamoxifen, but our results suggest that these concerns are unjustified with respect to depression. While cancer-specific variables were of minor importance, socio-economic and general health-related factors seem to play a substantial role as risk factors for depressive symptoms. It is possible that the influence of these risk factors is even more pronounced in countries with greater inequality in public access to adequate health services and treatment. The results calls for considerations about establishing screening procedures for major depression in breast-cancer, in order to provide adequate support and treatment to those who are in need.
